Page last updated: 2024-09-04

canertinib and Medulloblastoma

canertinib has been researched along with Medulloblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Bont, ES; den Dunnen, WF; Diks, SH; Hoving, EW; Lourens, HJ; Meeuwsen-de Boer, T; Plasschaert, SL; Zomerman, WW	1

Other Studies

1 other study(ies) available for canertinib and Medulloblastoma

Article	Year
Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines. PloS one, 2015, Volume: 10, Issue:10 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crizotinib; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Hepatocyte Growth Factor; Humans; Medulloblastoma; Morpholines; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Signal Transduction	2015

Article

Year

Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines.

PloS one, 2015, Volume: 10, Issue:10

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crizotinib; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Hepatocyte Growth Factor; Humans; Medulloblastoma; Morpholines; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Signal Transduction

2015